» Articles » PMID: 35629322

Lymphatic and Blood Endothelial Extracellular Vesicles: A Story Yet to Be Written

Overview
Journal Life (Basel)
Specialty Biology
Date 2022 May 28
PMID 35629322
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs), such as exosomes, microvesicles, and apoptotic bodies, are cell-derived, lipid bilayer-enclosed particles mediating intercellular communication and are therefore vital for transmitting a plethora of biological signals. The vascular endothelium substantially contributes to the circulating particulate secretome, targeting important signaling pathways that affect blood cells and regulate adaptation and plasticity of endothelial cells in a paracrine manner. Different molecular signatures and functional properties of endothelial cells reflect their heterogeneity among different vascular beds and drive current research to understand varying physiological and pathological effects of blood and lymphatic endothelial EVs. Endothelial EVs have been linked to the development and progression of various vascular diseases, thus having the potential to serve as biomarkers and clinical treatment targets. This review aims to provide a brief overview of the human vasculature, the biology of extracellular vesicles, and the current knowledge of endothelium-derived EVs, including their potential role as biomarkers in disease development.

Citing Articles

Endothelial cells release microvesicles that harbour multivesicular bodies and secrete exosomes.

Petersen J, Mekhedov E, Kaur S, Roberts D, Zimmerberg J J Extracell Biol. 2024; 2(4):e79.

PMID: 38939691 PMC: 11080864. DOI: 10.1002/jex2.79.


Analysis of extracellular vesicle microRNA profiles reveals distinct blood and lymphatic endothelial cell origins.

Pultar M, Oesterreicher J, Hartmann J, Weigl M, Diendorfer A, Schimek K J Extracell Biol. 2024; 3(1):e134.

PMID: 38938681 PMC: 11080916. DOI: 10.1002/jex2.134.


Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies.

Vahidinia Z, Azami Tameh A, Barati S, Izadpanah M, Hosseini E Cell Mol Biol Lett. 2024; 29(1):30.

PMID: 38431569 PMC: 10909300. DOI: 10.1186/s11658-024-00551-3.


Editorial: Manipulation of immune-vascular crosstalk in solid tumors.

Kumar V Front Immunol. 2023; 14:1295953.

PMID: 37868975 PMC: 10585256. DOI: 10.3389/fimmu.2023.1295953.


Exosomes from Adipose-Derived Stem Cells Alleviate Dexamethasone-Induced Bone Loss by Regulating the Nrf2/HO-1 Axis.

Yao X, Liu Z, Ma N, Jiang W, Zhou Z, Chen B Oxid Med Cell Longev. 2023; 2023:3602962.

PMID: 36778207 PMC: 9908349. DOI: 10.1155/2023/3602962.


References
1.
Wei D, Zhan W, Gao Y, Huang L, Gong R, Wang W . RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 2020; 31(2):157-177. PMC: 8027411. DOI: 10.1038/s41422-020-00409-1. View

2.
Todorova D, Simoncini S, Lacroix R, Sabatier F, Dignat-George F . Extracellular Vesicles in Angiogenesis. Circ Res. 2017; 120(10):1658-1673. PMC: 5426696. DOI: 10.1161/CIRCRESAHA.117.309681. View

3.
Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H . Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007; 110(7):2432-9. PMC: 2495018. DOI: 10.1182/blood-2007-02-069997. View

4.
Marziano C, Genet G, Hirschi K . Vascular endothelial cell specification in health and disease. Angiogenesis. 2021; 24(2):213-236. PMC: 8205897. DOI: 10.1007/s10456-021-09785-7. View

5.
Fleischer J, Jodszuweit C, Ghadimi M, De Oliveira T, Conradi L . Vascular Heterogeneity With a Special Focus on the Hepatic Microenvironment. Front Physiol. 2020; 11:591901. PMC: 7686534. DOI: 10.3389/fphys.2020.591901. View